Company / Total Assets
SELLAS Life Sciences Group, Inc. Total Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$19.4M
FY2024
5-year range
$6.2M / $46.0M
FY2020-FY2024
Trend
+212.5%
vs FY2023
Sector context
#212 of 214
Health Care
What the data says
Total Assets changed +212% YoY in FY2024, a notable deviation from the 9-year average annual change of +59%.
Based on SEC 10-K filings.
$19M in FY2024 with a 5-year CAGR of +3.2%.
Declined from $21M to $19M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -9.6%
- 5-Year CAGR
- +3.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 214This company $19.4M Sector average $7.5B
▼
-99.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.2%, indicating consistent growth.
- In FY2024, total assets increased 212.5% year-over-year.
- Ranks #212 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $19.4M | +212.5% |
| FY2023 | $6.2M | -70.3% |
| FY2022 | $20.9M | -20.3% |
| FY2021 | $26.3M | -42.9% |
| FY2020 | $46.0M | +177.3% |
| FY2019 | $16.6M | -1.8% |
| FY2018 | $16.9M | -49.5% |
| FY2017 | $33.5M | +422.2% |
| FY2016 | $6.4M | -92.2% |
| FY2015 | $82.1M | +2.1% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026